• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

VIDEO: Richard Stefanacci, DO, Addresses Cost Concerns of Neurodegenerative Diseases

Article

Richard Stefanacci, DO, Associate Professor, Health Policy & Public Health, University of the Sciences, says there are 2 cost concerns associated with neurodegenerative diseases.

Richard Stefanacci, DO, Associate Professor, Health Policy & Public Health, University of the Sciences, says there are 2 cost concerns associated with neurodegenerative diseases. One is the actual cost of the disease and the second is the cost of diagnostic testing. Dr Stefanacci also says that treatments are now currently inexpensive, but with new emerging therapiess the costs will rise.

This video was taken on Thursday, November 8 at the NAMCP Fall Forum in Las Vegas, NV.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
AHA 2025 recap layered on photo of Bourbon Street in New Orleans | Image credit: SeanPavonePhoto - stock.adobe.com
Screenshot of an interview with Stephen Nicholls, MBBS, PhD
Screenshot of an interview with Roy Mathew, MD
Screenshot of an interview with Vallerie McLaughlin, MD
Oncology experts at PCOC
Susan Cantrell, CEO of AMCP
Michael Hassett, MD, MPH
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.